Cutter Capital Management, LP Harmony Biosciences Holdings, Inc. Transaction History
Cutter Capital Management, LP
- $331 Billion
- Q2 2024
A detailed history of Cutter Capital Management, LP transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Cutter Capital Management, LP holds 295,771 shares of HRMY stock, worth $10.4 Million. This represents 2.69% of its overall portfolio holdings.
Number of Shares
295,771Holding current value
$10.4 Million% of portfolio
2.69%Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
237Shares Held
45.5MCall Options Held
48.2KPut Options Held
56.5K-
Valor Management LLC Chicago, IL11.2MShares$394 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$205 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.52MShares$123 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$91.4 Million11.62% of portfolio
-
Pacer Advisors, Inc. Malvern, PA1.93MShares$67.6 Million0.18% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.08B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...